Neuroimaging genomic studies in major depressive disorder: a systematic review
journal contribution
posted on 2018-11-01, 00:00 authored by Hui-Feng Zhang, David MellorDavid Mellor, Dai-Hui PengGenetic-neuroimaging studies could identify new potential endophenotypes of major depressive disorder (MDD). Morphological and functional alterations may be attributable to genetic factors that regulate neurogenesis and neurodegeneration. Given that the association between gene polymorphisms and brain morphology or function has varied across studies, this systematic review aims at evaluating and summarizing all available genetic-neuroimaging studies. Twenty-eight gene variants were evaluated in 64 studies by structural or functional magnetic resonance imaging. Significant genetic-neuroimaging associations were found in monoaminergic genes, BDNF genes, glutamatergic genes, HPA axis genes, and the other common genes, which were consistent with common hypotheses of the pathogenesis of MDD.
History
Journal
CNS neuroscience and therapeuticsVolume
24Issue
11Season
Special Issue on Imaging Connectomics in DepressionPagination
1020 - 1036Publisher
John Wiley & SonsLocation
Chichester, Eng.Publisher DOI
Link to full text
eISSN
1755-5949Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, John Wiley & Sons LtdUsage metrics
Read the peer-reviewed publication
Categories
Keywords
genomicsmajor depressive disorderneuroimagingpathophysiologyScience & TechnologyLife Sciences & BiomedicineNeurosciencesPharmacology & PharmacyNeurosciences & NeurologySEROTONIN TRANSPORTER POLYMORPHISMFACTOR VAL66MET POLYMORPHISMREDUCED HIPPOCAMPAL VOLUMESWHITE-MATTER INTEGRITYDEFAULT-MODE NETWORKNEUROTROPHIC FACTORIMAGING GENETICSAMYGDALA ACTIVITYPARAHIPPOCAMPAL CINGULUMGSK3-BETA POLYMORPHISMS